Day 2: October 17th, 2024
9:00 – 10:30 – Session 5 – Plenary 2 – Artifical Intelligence in healthcare and research – Salle ORSAY
This session aims to highlight and discuss the implications and fast changing developments across AI technology and regulations:
- For healthcare practitioners using assistive and autonomous AI to deliver care and the role of practitioner autonomy and decision-making
- For patient access to quality care and the autonomy, and the rising anxiety against data bias
- For researchers to understand regulatory position to reuse data and the risks of working with data analytics, where data bias may exist, and incomplete data may result in AI skewing results.
10:30 – 11:00 – Coffee Break
11:00 – 12:30 Session 8 – Panel Discussion – Standardization of Impact Assessments (Interplay between, DPIA, AI ACT, GDPR and MDR) and a common assessment framework for multiple regulations: CTR, MDR, AIA and GDPR – Salle ORSAY
Data Protection Impact Assessments are a mandatory part of clinical trials and represent a significant workload for project teams. Moreover, they will need frequently to integrate the assessment of the Artificial Intelligence systems used for the processing of personal health data.
11:00 – 12:30 Session 13 – Tuto/WS/PD – Cybersecurity with health apps – Salle Vendôme 5-6
1. Challenge the Existing Paradigm :
Expose the vulnerabilities of current health apps, questioning the very foundation of trust and security in digital health ecosystems.
2. Hack the Future :
Explore radical, forward-thinking solutions to protect health data in an era of quantum computing, decentralized networks, and AI-driven health apps.
3. Weaponize Data for Good :
Understand how personal health data, when secured, can become a powerful tool for personalized medicine and public health — but in the wrong hands, a weapon against individuals and society.
4. Embrace the Chaos: Cyber Resilience:
Prepare for the inevitable breaches and attacks. Learn how to design health apps that not only survive but thrive in a hostile cybersecurity landscape.
5. Anarchy in the API:
Dive into the future of API security, anticipating the next wave of threats in interconnected health systems. Discover how a radical overhaul in API design could redefine security standards for all health apps.
6.The Punk Manifesto for Health Data Security:
Draft a futuristic, rebellious manifesto on how health apps should evolve to protect privacy, build trust, and create systems that empower patients, even as technological landscapes shift unpredictably.
11:00 – 12:30
Session 10 – Panel Discussion 4 – Anomymization, pseudonymization, synthetic data (Legal)
– Salle Vendôme 1
12:30 – 13:30 – Lunch
13:30 – 15:00 Workshops Sessions
13:30 – 15:00 Session 9 – Panel Discussion 3 – Ethics, AI & personal data in health care – Salle ORSAY
13:30 – 15:00 Session 11 – Work Shop 4 – Anomymization, pseudonymizatio, synthetic data (Technical) – Salle Vendôme 5-6
In the era of big data, protecting personal information has never been more critical. But how effective are anonymization processes in reality? Are datasets truly anonymous, or just pseudonymous? And most importantly, can anonymized data still provide value to our industry? Join our expert panel to dive into these pressing questions and more. This session promises to spark a lively and thought-provoking debate on the efficiency and utility of anonymization techniques. Don’t miss the chance to engage with leaders who are shaping the future of Data Privacy in our Industry.
15:00 – 15:30 – Coffee Break
15:30 – 17:00
Session 12 – European Health Data Space – Salle ORSAY
This session aims to highlight those measures in the EHDS regulation that are expected to have implications for DPOs:
- matters that healthcare organisations will need to have robust approaches to inform patients about, collect consent or opt out choices about
- matters that regional and national health agencies will have to orchestrate through their healthcare providers and to engage with the public about
- matters that data users such as clinical research will need to take account of
17:00 – 18:15 Session – Oral Communications – Salle ORSAY
17:00-17:15 Sergio Contrino
- DATA INTEROPERABILITY IN THE VACCELERATE PROJECT: WHY IT MATTERS AND MAKING IT MEANINGFUL Salma Malik PharmB, PhD, Zoi Dorothea Pana, MD, MSc, PhD, Christos D. Argyropoulos , MSci, MSc, PhD, Sophia C. Themistocleous, MSc, Alan Macken ,MSc, Olena Valdenmaiier ,MSc, Frank Scheckenbach ,PhD, Elena Bardach, ,MSC, Andrea Pfeiffer, MS, Katherine Loens, PhD, Jordi Ochando ,PhD, Oliver A. Cornely, MD, PhD , Jacques Demotes , MBA, MD, PhD, Sergio Contrino, ING, Gerd Felder1, BS, MS.
17:15-17:30 Veronica Mino
- THE SECONDARY USE OF GENETIC DATA: BUILDING UP ON THE OPINION OF THE CONFERENCE OF INDEPENDENT FEDERAL AND STATE DATA PROTECTION SUPERVISORY AUTHORITIES (DSK) V. Miño-Vásquez, PhD
17:30-17:45 Chawla Kartik
- Navigating Muddy Data-Streams: PETs and EU Data Protection Laws in Secondary Health Data Use Kartik Chawla, Dayana Spagnuelo, Simon Dalmolen
17:45-18:00 Tatiana Revenco
- Health Data Secondary Use: Navigating the Balance Between Innovation and Data Protection
18:00-18:15 Ashley PITCHER
-
Patient-Mediated approach to sourcing secondary data for research in Europe Ashley B Pitcher, DPhil and Elena Koshkina, PhD
18:15 – 19:00 Closing Plenary – Session 16 – Transparency – Salle ORSAY
19:00 – 20:00 – Networking Cocktail followed by Cocktail & Dinner